EBGLYSS

Google image searchProduct monograph

Active ingredient

lebrikizumab, 250 MG/2 ML

DIN: 02549131

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PREFILLED SYRINGE

Schedule: Prescription / Schedule D

Company: ELI LILLY CANADA INC

Date: 26-NOV-2024

ATC:

• D11 — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD, )
• D11A — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD)
• D11AH — Agents for atopic dermatitis, excluding corticosteroides (ATC, ATC/DDD)
• D11AH10 — LEBRIKIZUMAB (ATC/DDD)

Reference brand drug: Ebglyss

External Links for Ebglyss

Search on Google

• Ebglyss side effects
• Ebglyss dosage
• lebrikizumab side effects
• lebrikizumab dosage

Eli Lilly Canada Inc

Go to Eli Lilly website to see drug product details. Sometimes you can find ebglyss photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.